Circulation[journal] 检索结果

7821. Defibrillator Lead Survival: Where Is the Threshold?

作者: Emily P Zeitler.;Kimberly A Selzman.
来源: Circ Cardiovasc Qual Outcomes. 2020年13卷4期e006649页

7822. Active Surveillance of the Implantable Cardioverter-Defibrillator Registry for Defibrillator Lead Failures.

作者: Frederic S Resnic.;Arjun Majithia.;Sanket S Dhruva.;Henry Ssemaganda.;Susan Robbins.;Danica Marinac-Dabic.;Kathleen Hewitt.;Lucila Ohno-Machado.;Matthew R Reynolds.;Michael E Matheny.
来源: Circ Cardiovasc Qual Outcomes. 2020年13卷4期e006105页

Several defibrillator leads have been recalled due to early lead failure leading to significant patient harm. Confirming the safety of contemporary defibrillator leads is essential to optimizing treatment for patients receiving implantable cardioverter-defibrillators (ICDs). We therefore sought to assess the comparative long-term safety of the 4 most commonly implanted ICD leads within the National Cardiovascular Data Registry ICD Registry.

7823. Response by Ahmad et al to Letter Regarding Article, "Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials".

作者: Yousif Ahmad.;James P Howard.;Darrel P Francis.
来源: Circ Cardiovasc Qual Outcomes. 2020年13卷4期e006642页

7824. Response by Nallamothu to Letter Regarding Article, "Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials".

作者: Brahmajee K Nallamothu.
来源: Circ Cardiovasc Qual Outcomes. 2020年13卷4期e006720页

7825. Letter by Boden Regarding Article, "Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials".

作者: William E Boden.
来源: Circ Cardiovasc Qual Outcomes. 2020年13卷4期e006632页

7826. Letter by Stetson et al Regarding Article, "Episode Payments for Transcatheter and Surgical Aortic Valve Replacement".

作者: Robert Leister Stetson.;Gregory B Kruse.;Joseph E Bavaria.
来源: Circ Cardiovasc Qual Outcomes. 2020年13卷4期e006493页

7827. Rivaroxaban Versus Apixaban for Stroke Prevention in Atrial Fibrillation: An Instrumental Variable Analysis of a Nationwide Cohort.

作者: Anders N Bonde.;Torben Martinussen.;Christina J-Y Lee.;Gregory Y H Lip.;Laila Staerk.;Casper N Bang.;Jay Bhattacharya.;Gunnar Gislason.;Christian Torp-Pedersen.;Jonas Bjerring Olesen.;Mark A Hlatky.
来源: Circ Cardiovasc Qual Outcomes. 2020年13卷4期e006058页

The comparative effectiveness of non-vitamin K antagonist oral anticoagulants (NOACs) is uncertain, as they have not been compared directly in randomized trials. Previous observational comparisons of NOACs are likely to be biased by unmeasured confounders. We sought to compare the efficacy and safety of rivaroxaban and apixaban for stroke prevention in patients with atrial fibrillation (AF), using practice variation in preference for NOAC as an instrumental variable.

7828. Finding Order in Chaos: Can Instrumental Variables Help Us Understand Observed Treatment Effects?

作者: Xiaoxi Yao.;Peter A Noseworthy.
来源: Circ Cardiovasc Qual Outcomes. 2020年13卷4期e006650页

7829. The Big MAC Attack on Peripheral Artery Disease.

作者: Aruna D Pradhan.;Aaron W Aday.;Joshua A Beckman.
来源: Circulation. 2020年141卷15期1211-1213页

7830. Willingness to Pay for High-Cost Medications.

作者: Mark A Hlatky.
来源: Circulation. 2020年141卷15期1225-1226页

7831. Response by Ortega-Paz et al to Letter Regarding Article, "Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial".

作者: Luis Ortega-Paz.;Salvatore Brugaletta.;Josep Gómez-Lara.;Manel Sabaté.
来源: Circulation. 2020年141卷15期e748-e749页

7832. Preventing Atrial Fibrillation With Treatments for Diabetes Mellitus.

作者: Christopher B Granger.;Kenneth W Mahaffey.
来源: Circulation. 2020年141卷15期1235-1237页

7833. Knockout of the Murine Ortholog to the Human 9p21 Coronary Artery Disease Locus Leads to Smooth Muscle Cell Proliferation, Vascular Calcification, and Advanced Atherosclerosis.

作者: Yoko Kojima.;Jianqin Ye.;Vivek Nanda.;Ying Wang.;Alyssa M Flores.;Kai-Uwe Jarr.;Pavlos Tsantilas.;Liang Guo.;Aloke V Finn.;Renu Virmani.;Nicholas J Leeper.
来源: Circulation. 2020年141卷15期1274-1276页

7834. Cardiac Imaging on the Cusp of an Artificial Intelligence Revolution.

作者: Bridget M Kuehn.
来源: Circulation. 2020年141卷15期1266-1267页

7835. Conduction Abnormalities and Ischemic Cardiomyopathy in an 84-Year-Old Man.

作者: Michael Jiang.;Bradley P Knight.;Nishant Verma.
来源: Circulation. 2020年141卷15期1268-1270页

7836. Letter by Consuegra-Sánchez et al Regarding Article, "Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial".

作者: Luciano Consuegra-Sánchez.;Peter Ong.;Juan Carlos Kaski.
来源: Circulation. 2020年141卷15期e746-e747页

7837. Considerations for Triaging Elective Cases in Children With Cardiac Disease in a Time of Crisis.

作者: Dana B Gal.;Danton S Char.
来源: Circulation. 2020年142卷9期824-826页

7838. Reperfusion of ST-Segment-Elevation Myocardial Infarction in the COVID-19 Era: Business as Usual?

作者: Matthew J Daniels.;Mauricio G Cohen.;Anthony A Bavry.;Dharam J Kumbhani.
来源: Circulation. 2020年141卷24期1948-1950页

7839. COVID-19 and Renin Angiotensin Blockers: Current Evidence and Recommendations.

作者: Franz H Messerli.;George C M Siontis.;Emrush Rexhaj.
来源: Circulation. 2020年141卷25期2042-2044页

7840. Catheter Ablation in Patients With Cardiogenic Shock and Refractory Ventricular Tachycardia.

作者: Jad A Ballout.;Oussama M Wazni.;Khaldoun G Tarakji.;Walid I Saliba.;Mohamed Kanj.;Mohamed Diab.;Mandeep Bhargava.;Bryan Baranowski.;Thomas J Dresing.;Thomas D Callahan.;Daniel J Cantillon.;John Rickard.;David O Martin.;Niraj Varma.;Mark J Niebauer.;Mina K Chung.;Patrick J Tchou.;Bruce D Lindsay.;Ayman A Hussein.
来源: Circ Arrhythm Electrophysiol. 2020年13卷5期e007669页

There is paucity of data regarding radiofrequency ablation for ventricular tachycardia (VT) in patients with cardiogenic shock and concomitant VT refractory to antiarrhythmic drugs on mechanical support.

结果排序

文献格式

出版时间

出版类型

出版语言